Antithrombotic Therapy Post Endovascular Stenting for Superior Vena Cava Syndrome

Herscovici R Szyper-kravitz M Altman A et al . Superior vena cava syndrome—changing etiology in the third millennium. Lupus. 2012;21:93-96.

Rice TW Rodriguez RM Light RW . The superior vena cava syndrome: clinical characteristics and evolving etiology. Medicine. 2006;85:37-42.

Rumbaut RE Thiagarajan P . Arterial, venous, and microvascular hemostasis/thrombosis. In: Granger DN Granger J , eds. Platelet-Vessel Wall Interactions in Hemostasis and Thrombosis. San Rafael, CA: Morgan & Claypool Life Sciences; 2010:35-42.

Lanciego C Pangua C Chacon JI et al . Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome. AJR Am J Roentgenol. 2009;193:549-558.

Fagedet D Thony F Timsit JF et al . Endovascular treatment of malignant superior vena cava syndrome: results and predictive factors of clinical efficacy. Cardiovasc Intervent Radiol. 2013;36:140-149.

Gross CM Kramer J Waigand J et al . Stent implantation in patients with superior vena cava syndrome. AJR Am J Roentgenol. 1997;169(2):429-432.

Monaco RG Bertoni H Pallota G et al . Use of self-expanding vascular endoprostheses in superior vena cava syndrome. Eur J Cardiothorac Surg. 2003;24(2):208-211.

Marcy PY Magne N Bentolila F et al . Superior vena cava obstruction: is stenting necessary? Support Care Cancer. 2001;9(2):103-107.

Thony F Moro D Witmeyer P et al . Endovascular treatment of superior vena cava obstruction in patients with malignancies. Eur Radiol. 1999;9(5):965-971.